| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.39B | -1.8% |
| Cost of Revenue | $195.6M | +4.0% |
| R&D Expense | $74.1M | -6.1% |
| SG&A Expense | $404.3M | -11.5% |
| Operating Income | $198.9M | +18.9% |
| Interest Expense | $37.1M | -53.4% |
| Pre-tax Income | $131.2M | -62.7% |
| Income Tax | $58.0M | +508.2% |
| Net Income | $63.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $652.8M | -6.1% |
| Short-term Investments | $58.4M | -74.5% |
| Accounts Receivable | $304.7M | -3.7% |
| Current Assets | $1.08B | -16.6% |
| Total Assets | $3.53B | -6.3% |
| Current Liabilities | $432.4M | -13.0% |
| Long-term Debt | $999.1M | -8.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $336.4M | -34.9% |
| Capital Expenditures | $106.2M | -6.7% |
| Investing Cash Flow | -$220.8M | -473.6% |
| Financing Cash Flow | -$140.8M | -24.5% |
| Free Cash Flow | $230.3M | -42.8% |
| -87.2% |
| EPS (Basic) | $1.36 | -87.4% |
| EPS (Diluted) | $1.36 | -86.9% |
| Total Liabilities |
| $1.64B |
| -9.0% |
| Stockholders' Equity | $1.89B | -3.8% |